CARR EDWARD bought DNTH
March 12, 2026 · Form 4 insider transaction
CARR EDWARD bought 10,000 shares of Dianthus Therapeutics, Inc. at $21.77 per share, a transaction worth $217.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$21.77
Total value
$217.7K
InsiderCARR EDWARD
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 12, 2026
Filing dateMarch 13, 2026
Shares owned after43,682
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025.